Welcome to our dedicated page for Cactus Acquisition 1 Unit news (Ticker: CCTSU), a resource for investors and traders seeking the latest updates and insights on Cactus Acquisition 1 Unit stock.
Cactus Acquisition Corp. 1 Limited Unit (symbol: CCTSU) is a blank check company formed for the purpose of effecting a merger, share exchange, or business combination with a technology-based healthcare business in Israel. Led by Chairman Nachum (Homi) Shamir, CEO Ofer Gonen, and CFO Stephen T. Wills, the company focuses on Israel-related technology-based healthcare companies.
Cactus Acquisition Corp. 1 Ltd. (Nasdaq: CCTS) has announced plans for an extraordinary meeting on April 20, 2023, to vote on extending the deadline for its initial business combination from May 2, 2023, to November 2, 2023. This extension requires approval from shareholders and aims to enable further strategic opportunities. The Company’s sponsor, Cactus Healthcare Management, will contribute funds to the trust account, potentially amounting to $40,000 or $0.02 per public share. Additionally, any funds will remain untouched for excise tax payments under the Inflation Reduction Act of 2022. If approved, the Sponsor will also convert its Class B shares into Class A shares, increasing the number of outstanding Class A shares. The trust account will yield interest at approximately 4.5% per annum, although this rate may vary.
Cactus Acquisition Corp. 1 Limited (NasdaqGM: CCTS, CCTSU and CCTSW) filed its annual report on Form 10-K for the year ending December 31, 2021, with the SEC on March 31, 2022. The company is focused on mergers and acquisitions in technology-based healthcare sectors, particularly those related to Israel. Led by CEO Ofer Gonen, the firm aims to combine with innovative businesses in this space. The report and other filings can be accessed on the company website or the SEC's site.
Cactus Acquisition Corp. 1 Limited (CCTSU) announced that starting December 30, 2021, investors can trade Class A ordinary shares and warrants from their IPO units separately. The Class A shares will trade under the symbol 'CCTS' and the warrants under 'CCTSW.' Current units will continue to trade as 'CCTSU.' This press release clarifies that it does not constitute an offer to sell securities and includes forward-looking statements regarding the company's future, which may differ materially from actual results.
Cactus Acquisition Corp. 1 Limited has successfully closed its upsized initial public offering of 12,650,000 units at a price of $10.00 each, totaling $126,500,000. Each unit comprises one Class A ordinary share and one-half redeemable warrant, with full warrant exercise allowing purchase at $11.50. The units now trade on Nasdaq under the symbol 'CCTSU.' The company aims to identify merger opportunities with technology-focused healthcare firms in Israel. Oppenheimer & Co. Inc. and Moelis & Company LLC managed the offering.
Cactus Acquisition Corp. 1 Limited has announced that its underwriters fully exercised their over-allotment option on October 29, 2021, leading to the issuance of an additional 1,650,000 units at a price of $10.00 each. This brings the total units issued in their initial public offering to 12,650,000, with an aggregate offering price of $126,500,000. Each unit consists of one Class A ordinary share and a half warrant, with the total expected listing on Nasdaq under the symbols 'CCTS' and 'CCTSW'. The company is focused on mergers in the Israel-related technology healthcare sector.
Cactus Acquisition Corp. 1 Limited has priced its initial public offering (IPO) at $10.00 per unit, offering a total of 11,000,000 units. The IPO is set to trade on Nasdaq under the symbol 'CCTSU' starting October 29, 2021. Each unit comprises one Class A ordinary share and a half warrant, with a whole warrant priced at $11.50. The company focuses on merger opportunities within Israel-related tech-based healthcare. Underwriters have an option for an additional 1,650,000 units for up to $16.5 million in gross proceeds. The SEC's registration statement was effective as of October 28, 2021.
Cactus Acquisition Corp. 1 Limited has initiated a roadshow for its IPO, aiming to offer 10 million units at $10 each, consisting of one Class A ordinary share and one-half of a redeemable warrant. Each full warrant allows the purchase of a share at $11.50. The units will trade on Nasdaq under the ticker symbol CCTSU. Oppenheimer & Co. Inc. and Moelis & Company LLC are the joint book-running managers. The registration statement has been filed with the SEC but is not yet effective, and securities cannot be sold until it is.
FAQ
What is the current stock price of Cactus Acquisition 1 Unit (CCTSU)?
What is the purpose of Cactus Acquisition Corp. 1 Limited?
Who are the key leaders at Cactus Acquisition Corp. 1 Limited?
What is the focus of Cactus Acquisition Corp. 1 Limited in terms of business combinations?
When is the extraordinary general meeting of Cactus Acquisition Corp. 1 Limited taking place?
What actions are being undertaken by Cactus Acquisition Corp. 1 Limited in preparation for the meeting?
What happens if a Contributor fails to make a required Contribution for Cactus Acquisition Corp. 1 Limited?
How does Cactus Acquisition Corp. 1 Limited handle trust funds in relation to excise taxes?
Where will trust funds be held if Cactus Acquisition Corp. 1 Limited chooses to liquidate government treasury obligations or money market funds?
Are there any forward-looking statements associated with Cactus Acquisition Corp. 1 Limited?
How can investors access more information about Cactus Acquisition Corp. 1 Limited and the upcoming meeting?
